The maker of opioid painkiller Opana ER is pulling the drug off the market at the request of federal regulators because it’s being abused. Opioid Opana ER, approved in 2006, is too risky, the FDA says. Currently, there are no generic versions on the market.…
The Court of Appeals found that the Blakelys did not bring forth evidence to support their claim, and affirmed the lower court’s grant of summary judgment to USAA.
The Court of Appeals examined each defendant in light of those two questions, and found that yes, the court did have personal jurisdiction over the defendants.
Lawsuits over retrievable IVC filters continue to grow. In two separate federal litigations there are almost 4000 filings against Cook Medical and C.R. Bard, the two largest manufacturers of IVC filters. Another smaller manufacturer, Cordis Corporation is facing nearly 200 IVC filter lawsuits. Manuf
The Supreme Court also examined whether the Colorado legislature, in writing that statute, negated the common law principles of implied authority and apparent authority.
For the second time in a little more than a month, the FDA warned of accuracy errors associated with stereotaxic navigation systems—a computer system that “guides” surgeons within the body in real-time by using 3D-like imaging—most often employed during brain or spinal surgery. The…
Scott did not back up her claims with any evidence to contradict the lower court’s determination. The court found no plain error in the record and affirm the compensation court’s determination.
Congress has recently taken several bills under consideration related to tort reform. If these bills are passed, they could limit, eliminate, or significantly change individual’s access to the justice. On June 28, 2017, the House is to vote on “Protecting Access to Care Act of…
